LifeX Ventures
VC Fund
New York, United States
LifeX Ventures is a venture capital firm that supports scientists and entrepreneurs launching technologies that extend the longevity of people and planet. The firm prefers to invest in various sectors, including Web3, payments, data, security, APIs, marketplaces, analytics, neural networks, transportation and logistics, food and agriculture,medicine, energy, genomics and synthetic biology, nootropics, and science-related industries.
- Total investments:
- 35
- Last investment:
- Lead investor:
- 9%
- Fund size:
- $27M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries LifeX Ventures invests in
Stages LifeX Ventures invests in
Countries LifeX Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Investment Focus
Industry
- Health Care 11 (31%)
- Artificial Intelligence 11 (31%)
- Software 8 (23%)
- Information Technology 5 (14%)
- Machine Learning 4 (11%)
Stage
- Seed 14 (40%)
- Series A 9 (26%)
- Pre-Seed 5 (14%)
- Series C 1 (3%)
- Venture - Series Unknown 1 (3%)
Country
- United States 17 (49%)
- Spain 3 (9%)
- Israel 1 (3%)
- Denmark 1 (3%)
- Germany 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Fabian Siegel
Venture Partner
|
Venture Partner | Total investments: 3 | Find email | |
Veeral Mehta
Associate/Investor
|
Associate/Investor | Total investments: 0 | Find email | |
Amalia Formoso
CFO
|
CFO | Total investments: 0 | Find email | |
Amol Sarva
Managing Partner
|
Managing Partner | Total investments: 14 | Find email | |
Fernando Lopez
Financial Controller
|
Financial Controller | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Axo Longevity offers membership-based biomarker testing and digital health plans for preventive wellness and longevity optimization. | $5M / Seed / Sep 15, 2026 | ||
| We are building the AI-native operating system for clinics. Our proprietary agent, Kora, is the front door to the clinic—engaging patients 24/7 on WhatsApp and web, qualifying leads, answering questions, scheduling visits, and escalating to staff when needed. Clinics using Kora capture more patients, ease staff burnout, and unlock 50%+ growthin bookings without changing their existing systems. | $6M / Seed / Sep 02, 2026 | ||
| Aisel is a psychiatry AI tool for clinicians that makes clinical documents safer to sign. General scribes transcribe a conversation into a note; Aisel works on the documents where being wrong is expensive — expert court reports, tribunal and Mental Health Act reports, medico-legal certificates, capability and benefits reports.Upload thepatient's records once and generate what the case needs. Every statement is cited to its source with side-by-side verification. Contradictions between records — or with the patient's account — are flagged for your judgment, and a completeness check measures the report against what it must answer, so gaps surface while they're still fixable.Aisel never generates opinions: it assembles, cites and checks the evidence; the clinician authors the conclusions and signs. GDPR-compliant, ISO 27001-compliant, end-to-end encrypted, UK/EU data residency, patient data deleted at discharge. | $2M / Pre-Seed / Aug 19, 2026 | ||
| Integral focuses on compliantly connecting health data in a secure and efficient manner, serving as the only end-to-end regulated insights platform transforming compliance barriers into competitive advantage. We offer a range of products and services to help businesses accelerate their data processing, collaborate securely, and unlock new insights.Our software provides robust security and privacy protections while enabling seamless collaboration with regulated data. Our flagship offering is Expert Certifications-as-a-Service, which allows companies to work with de-identified data to discover novel insights and make innovative business decisions. Unlike traditional methods conducted by consultants that take months, our automated expert certification software drastically reduces processing time to mere hours.Through our expertise in privacy-enhancing technologies and deep understanding of healthcare data complexities, we help enterprises extract bespoke, actionable insights from regulated data that aren't available anywhere else, making us a valuable asset for any company looking to compliantly work with regulated data. | $18M / Series A / Jul 01, 2026 | ||
| We help local restaurants thrive!We are allO - the digital backbone of restaurants, the future of gastronomy, and the reliable partner of local businesses.Our mission is to give local restaurants unfair technology advantages to compete with prominent players. We strive to democratize gastronomy by making McDonald's and Starbucks'level of technology accessible to small restaurant owners. | $14M / Series A / May 26, 2026 | ||
| Stack is developing a set of tools to assist machine learning teams in perfecting their datasets by detecting data anomalies, evaluating annotations at scale, and protecting data with version control. | $16M / Series A / May 06, 2026 | ||
| NoTraffic develops traffic management technology that coordinates signalized intersections using connected vehicle data and AI-based control systems. Its platform integrates with existing traffic infrastructure to analyze real-time road conditions, detect vehicles, and adjust signal timing to improve traffic flow. The company provides software andhardware components that enable communication between vehicles, sensors, and traffic signals. Its system supports applications such as congestion reduction, emergency-vehicle prioritization, and pedestrian-safety management. NoTraffic also offers data insights and monitoring tools that allow municipalities and transportation agencies to manage and evaluate intersection performance. | $90M / Series C / Mar 24, 2026 | ||
| MITO combines a cutting-edge video studio with a clever creative suite designed for teams, filmmakers, and brands. | $4.5M / Pre-Seed / Jan 29, 2026 | ||
| InfiniteWatch provides a monitoring service for digital platforms. The system tracks web, voice, and AI agent interactions made through digital products. It collects data from these interactions to identify issues and opportunities for action. The service helps businesses understand how users interact with their online tools and services. It offersinsights that can support decision-making related to digital operations. The platform is designed to help organizations manage and review their digital performance. | $4M / Pre-Seed / Dec 18, 2025 | ||
| Curve Biosciences is a biotechnology company focused on enhancing chronic disease care through precision medicine. With a team led by experts such as Nathan Hunkapiller, PhD, as Chief Scientific Officer, and Chuba Oyolu, PhD, as Chief Technology Officer, the company is at the forefront of research and development in the biotech field. CurveBiosciences aims to leverage scientific advancements to provide targeted solutions for chronic diseases, emphasizing the importance of precision in treatment approaches. The company operates within the biotechnology industry and is dedicated to improving patient outcomes through innovative research. | $40M / Series A / Oct 29, 2025 | ||
| See all 35 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does LifeX Ventures invest in?
LifeX Ventures invests primarily in Health Care, Artificial Intelligence and Software startups, most often at Seed and Series A stage. Most of the 35 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact LifeX Ventures?
Public channels for LifeX Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at LifeX Ventures?
The team at LifeX Ventures includes Fabian Siegel (Venture Partner), Veeral Mehta (Associate/Investor) and Amalia Formoso (CFO), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
